Universal tumor screening for Lynch syndrome: Assessment of the perspectives of patients with colorectal cancer regarding benefits and barriers

By Hunter Jessica Ezzell   Zepp Jamilyn M.   Gilmore Mari J.   Davis James V.   Esterberg Elizabeth J.   Muessig Kristin R.   Peterson Susan K.   Syngal Sapna   Acheson Louise S.   Wiesner Georgia L.   Reiss Jacob A.   Goddard Katrina A.B.  

Cancer, Vol. 121, Iss. 18, 2015-09 ,pp. : 3281-3289

Blackwell Publishing

Access to resources Recommend Favorite

Initiation of universal tumor screening for Lynch syndrome in colorectal cancer patients as a model for the implementation of genetic information into clinical oncology practice

By Cohen Stacey A.   Laurino Mercy   Bowen Deborah J.   Upton Melissa P.   Pritchard Colin   Hisama Fuki   Jarvik Gail   Fichera Alessandro   Sjoding Britta   Bennett Robin L.   Naylor Lorraine   Jacobson Angela   Burke Wylie   Grady William M.  

Cancer, Vol. 122, Iss. 3, 2016-02 ,pp. : 393-401

Blackwell Publishing

Access to resources Recommend Favorite

Utility of MLH1 Methylation Analysis in the Clinical Evaluation of Lynch Syndrome in Women with Endometrial Cancer

By  

Current Pharmaceutical Design, Vol. 20, Iss. 11, 2014-04 ,pp. : 1655-1663

Bentham Science Publishers

Access to resources Recommend Favorite

POLE mutations as an alternative pathway for microsatellite instability in endometrial cancer: Implications for Lynch syndrome testing

By Konstantinopoulos Panagiotis A.   Matulonis Ursula A.  

Cancer, Vol. 121, Iss. 3, 2015-02 ,pp. : 331-334

Blackwell Publishing

Access to resources Recommend Favorite

Polymerase ɛ (POLE) mutations in endometrial cancer: Clinical outcomes and implications for Lynch syndrome testing

By Billingsley Caroline C.   Cohn David E.   Mutch David G.   Stephens Julie A.   Suarez Adrian A.   Goodfellow Paul J.  

Cancer, Vol. 121, Iss. 3, 2015-02 ,pp. : 386-394

Blackwell Publishing

Access to resources Recommend Favorite